Leadership
Sector
Medical Devices
Oculeve developed a nasal implant to treat dry eye by stimulating natural tear production. Acquired by Allergan in 2015 for $125 million, it was later FDA-approved as TrueTear™ in 2017.
Their story
.avif)
Our partnership
Working hand in hand with companies that transform healthcare is our privilege and responsibility.
.avif)